Alrise Biosystems
Berlin, Berlin, Germany
About Alrise Biosystems
ALRISE develops controlled release depot formulations for protein, peptide and small molecule drugs. The cornerstone of ALRISE’s business is its patented drug delivery technology for the encapsulation of hydrophilic or hydrophobic drug substances in biodegradable polymeric nano or micro particles. ALRISE not only offers a unique technology, but also provides a platform from which products can be developed to meet the ever increasing needs of pharma, biotech, and generics companies. ALRISE’s mission is to make its innovative encapsulation technology available to a broader user spectrum and ultimately to create benefit for patients worldwide.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Oct 2005)
- Website: alrise.de
- Phone: 49 30 94 89 24 83
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/alrise-biosystems-2535673 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.